Financial
Latest full-year results from official filings.
FY2025 revenue £223.9m (+22.2%); operating margin -69.4%; net loss £145.2m.
No debt; £302.8m cash.
- Official results release · Oxford Nanopore Technologies · 31 Dec 2025
Oxford Nanopore Technologies: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Aug 2025: Oxford Nanopore announced that co-founder and CEO Gordon Sanghera will step down by the end of 2026, with the board running a formal search for a successor.
- Chief Executive Officer Succession (RNS 7098U) · Oxford Nanopore Technologies via LSE RNS · 11 Aug 2025
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
Oct 2025: CISA advisory ICSMA-25-294-01 disclosed three vulnerabilities in Oxford Nanopore's MinKNOW sequencing software (two rated high), fixed in versions after 24.11. CISA reported no known public exploitation. NHS DSPT status not yet checked.
- ICSMA-25-294-01: Oxford Nanopore Technologies MinKNOW · CISA (via GCVE database) · 21 Oct 2025
- Study Exposes Critical Security Flaws in Widely Used DNA Sequencing Tech · AZoLifeSciences · 11 Nov 2025
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
No product recalls, safety notices or clinical safety actions involving Oxford Nanopore Technologies found in HSH's search of the last 24 months.
Contract performance
Contract delivery, go-lives, terminations and disputes.
No new notable contract awards, terminations or customer disputes involving Oxford Nanopore found in HSH's search of the last 24 months. Its pathogen surveillance partnership with the UK Government, NHS England and Genomics England (announced Nov 2024) was due to start in 2025.
- Oxford Nanopore announces landmark UK Government partnership to advance genomics-driven healthcare innovation in the UK · Oxford Nanopore Technologies · 5 Nov 2024